P1235 BASELINE/EARLY PRESENCE OF KNOWN AND NOVEL RESISTANCE MUTATIONS IS ASSOCIATED WITH VIRAL FAILURE IN DIFFICULT-TO-TREAT PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORSValeria Cento, Francesca Ceccherini‐Silberstein, Velia Chiara Di Maio et al.|Journal of Hepatology|2014Cited by 0
T-9 2-year effectiveness and safety of tenofovir in 302 NUC-naive patients with chronic hepatitis B: a multicenter European study in clinical practicePietro Lampertico, M. Colombo, R. Soffredini et al.|Digestive and Liver Disease|2012Cited by 0
P1168 ITPA AND SLC29A1 GENOTYPING BEFORE TRIPLE THERAPY PREDICT SEVERITY OF RIBAVIRIN-INDUCED ANEMIALaura Milazzo, Felicia Stefania Falvella, E. Clementi et al.|Journal of Hepatology|2014Cited by 0